Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines. | Clin Transl Oncol | 2022 | 34773566 | PubTator, text mining | PubMed |
| Lay understandings of drug-gene interactions: The right medication, the right dose, at the right time, but what are the right words? | Clin Transl Sci | 2022 | 34755460 | PubTator, text mining | PubMed |
| Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis. | Bone | 2022 | 34743040 | PubTator, text mining | PubMed |
| Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle. | Pharmacogenomics J | 2022 | 34741133 | PubTator, text mining | PubMed |
| Gene-environment interaction identification via penalized robust divergence. | Biom J | 2022 | 34725857 | PubTator, text mining | PubMed |
| Lessons learned from unsolicited findings in clinical exome sequencing of 16,482 individuals. | Eur J Hum Genet | 2022 | 34697415 | PubTator, text mining | PubMed |
| Novel 5-fluorouracil sensitizers for colorectal cancer therapy: Design and synthesis of S1P receptor 2 (S1PR2) antagonists. | Eur J Med Chem | 2022 | 34688013 | PubTator, text mining | PubMed |
Association of renal function with the safety and efficacy of cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in patients with advanced gastric cancer: an exploratory analysis of JCOG1013. | Jpn J Clin Oncol | 2022 | 34668562 | PubTator, text mining | PubMed |
| Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health. | Hum Genet | 2022 | 34652573 | PubTator, text mining | PubMed |
Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett's oesophagus and provides insights into clinical heterogeneity in reflux diagnosis. | Gut | 2022 | 34187846 | PubTator, text mining | PubMed |
| Boosting the oral bioavailability of anticancer drugs through intentional drug-drug interactions. | Basic Clin Pharmacol Toxicol | 2022 | 34117715 | PubTator, text mining | PubMed |
| Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial. | Gut | 2022 | 33980610 | PubTator, text mining | PubMed |
| Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur). | Acta Clin Belg | 2022 | 33423619 | PubTator, text mining | PubMed |
| 18F-flutemetamol positron emission tomography in cardiac amyloidosis. | J Nucl Cardiol | 2022 | 33025472 | PubTator, text mining | PubMed |
| Does dihydropyrimidine dehydrogenase level modify plasma antioxidant capacity in colorectal cancer patients treated with fluoropyrimidines? | Folia Med (Plovdiv) | 2021 | 35851211 | PubTator, text mining | PubMed |
| Protein Network Analysis of Whole Exome Sequencing of Severe Preeclampsia. | Front Genet | 2021 | 35719905 | PubTator, text mining | PubMed |
| Results of the implementation of a pharmacogenomics platform based on NGS technologies. Combining clinical and research approaches. | Farm Hosp | 2021 | 35379108 | PubTator, text mining | PubMed |
| Frequency and clinical relevance of DPYD genetic variants in gastrointestinal cancer patients. | Farm Hosp | 2021 | 35379107 | PubTator, text mining | PubMed |
| Updates on systemic therapy for cervical cancer. | Indian J Med Res | 2021 | 35295013 | PubTator, text mining | PubMed |
| Intratumoral gene expression of dihydrofolate reductase and folylpoly-c-glutamate synthetase affects the sensitivity to 5-fluorouracil in non-small cell lung cancer. | Discov Oncol | 2021 | 35201464 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=51